Literature DB >> 4077969

Demonstration of Toxoplasma antigen containing complexes in active toxoplasmosis.

F van Knapen, S O Panggabean, J van Leusden.   

Abstract

With an enzyme-linked immunosorbent assay antigen, specific circulating immune complexes (CIC) were demonstrated in experimental and human toxoplasmosis. In experimentally infected mice, CIC became demonstrable as soon as antibodies appeared after fatal infection. When a nonvirulent strain of Toxoplasma was used CIC remained detectable for several weeks. This period was characterized by clinically healthy animals with increasing antibody titers and by cysts growing in the brains of the animals, indicating a subacute stage of the toxoplasma infection. In the human sera, a surprisingly high percentage of CIC was demonstrated. Both immunoglobulin G (IgG) and IgM were found in the CIC; however, IgG was seen in the majority. If the humans were grouped according to other serological results, such as a combination with IgM antibodies, circulating antigens, or both, or a positive complement fixation test, increasingly more CIC were observed. When sera were selected from patients with clinical symptoms generally associated with toxoplasmosis, more CIC were also again demonstrated. On the contrary, in healthy individuals (blood donors), CIC were also regularly observed, suggesting that exacerbations of latent infections or reinfections may regularly occur without leading to clinical signs. In conclusion, we propose that the interpretation of a positive CIC test requires great care but may provide useful information about the activity of a toxoplasma infection.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4077969      PMCID: PMC268484          DOI: 10.1128/jcm.22.4.645-650.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Recurrent toxoplasmosis.

Authors:  R Norrby; T Eilard
Journal:  Scand J Infect Dis       Date:  1976

2.  Clinical and experimental investigation of immune complexes in malaria.

Authors:  V Houba; P H Lambert; A Voller; M A Soyanwo
Journal:  Clin Immunol Immunopathol       Date:  1976-07

3.  Late parasitemia in asymptomatic acquired toxoplasmosis.

Authors:  M J Miller; W J Aronson; J S Remington
Journal:  Ann Intern Med       Date:  1969-07       Impact factor: 25.391

4.  Circulating antigen-antibody complexes in onchocerciasis.

Authors:  M W Steward; B Sisley; C D Mackenzie; H El Sheikh
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

5.  Detection of toxoplasma antigen in tissues by means of enzyme-linked immunosorbent assay (ELISA).

Authors:  F van Knapen; S O Panggabean
Journal:  Am J Clin Pathol       Date:  1982-06       Impact factor: 2.493

6.  Laboratory diagnosis of toxoplasmosis by means of an ELISA triple test (detection of class-specific IgG, IgM and circulating antigens).

Authors:  F van Knapen; S O Panggabean
Journal:  Antonie Van Leeuwenhoek       Date:  1980       Impact factor: 2.271

7.  Detection of circulating antigen during acute infections with Toxoplasma gondii by enzyme-linked immunosorbent assay.

Authors:  F van Knapen; S O Panggabean
Journal:  J Clin Microbiol       Date:  1977-12       Impact factor: 5.948

8.  Immunosuppression and toxoplasmic encephalitis: clinical and experimental aspects.

Authors:  J K Frenkel; B M Nelson; J Arias-Stella
Journal:  Hum Pathol       Date:  1975-01       Impact factor: 3.466

9.  Antigenemia in recently acquired acute toxoplasmosis.

Authors:  F G Araujo; J S Remington
Journal:  J Infect Dis       Date:  1980-02       Impact factor: 5.226

10.  Human schistosomiasis: Schistosoma mansoni antigen detection in renal glomeruli.

Authors:  S Hoshino-Shimizu; T De Brito; H Y Kanamura; A L Canto; A O Silva; A R Campos; D O Penna; L C Da Silva
Journal:  Trans R Soc Trop Med Hyg       Date:  1976       Impact factor: 2.184

View more
  7 in total

1.  Toxoplasmosis in immunocompromised patients.

Authors:  F G Araujo; J S Remington
Journal:  Eur J Clin Microbiol       Date:  1987-02       Impact factor: 3.267

2.  Laboratory tests in uveitis. New developments in the analysis of local antibody production.

Authors:  A Kijlstra; G J van den Horn; L Luyendijk; G S Baarsma; C M Schweitzer; M J Zaal; Z Timmerman; M Beintema; A Rothova
Journal:  Doc Ophthalmol       Date:  1990-10       Impact factor: 2.379

3.  Serology in ocular toxoplasmosis.

Authors:  A Rothova; F van Knapen; G S Baarsma; P J Kruit; D H Loewer-Sieger; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1986-08       Impact factor: 4.638

4.  Presence of high concentrations of circulating Toxoplasma antigens during acute Toxoplasma infection in athymic nude mice.

Authors:  Y Suzuki; A Kobayashi
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

5.  Detection of circulating antigens in immunocompromised patients during reactivation of chronic toxoplasmosis.

Authors:  E Candolfi; F Derouin; T Kien
Journal:  Eur J Clin Microbiol       Date:  1987-02       Impact factor: 3.267

6.  Indirect enzyme-linked immunosorbent assay for immunoglobulin G and four immunoassays for immunoglobulin M to Toxoplasma gondii in a series of heart transplant recipients.

Authors:  J F Sluiters; A H Balk; C E Essed; B Mochtar; W Weimar; M L Simoons; E P Ijzerman
Journal:  J Clin Microbiol       Date:  1989-03       Impact factor: 5.948

7.  Toxoplasma gondii 70 kDa heat shock protein: systemic detection is associated with the death of the parasites by the immune response and its increased expression in the brain is associated with parasite replication.

Authors:  Paulo Victor Czarnewski Barenco; Elaine Vicente Lourenço; Jair Pereira Cunha-Júnior; Karine Cristine Almeida; Maria Cristina Roque-Barreira; Deise Aparecida Oliveira Silva; Ester Cristina Borges Araújo; Loyane Bertagnolli Coutinho; Mário Cézar Oliveira; Tiago Wilson Patriarca Mineo; José Roberto Mineo; Neide Maria Silva
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.